Biolase, Inc. (BIOL): Price and Financial Metrics


Biolase, Inc. (BIOL): $0.69

0.01 (+1.47%)

POWR Rating

Component Grades

Growth

S

Value

I

Momentum

G

Stability

N

Sentiment

U

Quality

P

BIOL POWR Grades


  • BIOL scores best on the Growth dimension, with a Growth rank ahead of 95.62% of US stocks.
  • BIOL's strongest trending metric is Sentiment; it's been moving up over the last 36 weeks.
  • BIOL's current lowest rank is in the Stability metric (where it is better than 5.21% of US stocks).

BIOL Stock Summary

  • With a market capitalization of $102,055,671, Biolase Inc has a greater market value than only 13.29% of US stocks.
  • The volatility of Biolase Inc's share price is greater than that of 87.74% US stocks with at least 200 days of trading history.
  • Shareholder yield, a measure of how much is returned to shareholders via dividends and share repurchases, for BIOL comes in at -28.21% -- higher than that of just 9.95% of stocks in our set.
  • Stocks that are quantitatively similar to BIOL, based on their financial statements, market capitalization, and price volatility, are XENT, AXGN, ATRC, STIM, and XXII.
  • BIOL's SEC filings can be seen here. And to visit Biolase Inc's official web site, go to www.biolase.com.

BIOL Valuation Summary

  • In comparison to the median Healthcare stock, BIOL's price/sales ratio is 5.26% lower, now standing at 3.6.
  • BIOL's price/sales ratio has moved down 1.7 over the prior 243 months.
  • Over the past 243 months, BIOL's price/earnings ratio has gone up 17.2.

Below are key valuation metrics over time for BIOL.

Stock Date P/S P/B P/E EV/EBIT
BIOL 2021-08-31 3.6 3.5 -8.4 -8.3
BIOL 2021-08-30 3.6 3.5 -8.6 -8.4
BIOL 2021-08-27 3.4 3.3 -8.1 -7.8
BIOL 2021-08-26 3.5 3.4 -8.1 -7.9
BIOL 2021-08-25 3.5 3.4 -8.3 -8.0
BIOL 2021-08-24 3.5 3.4 -8.1 -7.9

BIOL Growth Metrics

  • The year over year revenue growth rate now stands at -19.04%.
  • Its 3 year cash and equivalents growth rate is now at -52.13%.
  • Its 2 year cash and equivalents growth rate is now at -79.12%.
BIOL's revenue has moved up $53,000 over the prior 15 months.

The table below shows BIOL's growth in key financial areas (numbers in millions of US dollars).

Date Revenue Operating Cash Flow Net Income to Common Stock
2021-06-30 32.309 -13.464 -13.733
2021-03-31 26.113 -15.16 -17.728
2020-12-31 22.78 -12.795 -16.829
2020-09-30 24.442 -16.119 -14.278
2020-06-30 26.549 -15.458 -19.768
2020-03-31 32.256 -11.846 -18.97

BIOL's Quality Factors

The “Quality” component of the POWR Ratings focuses on 31 different factors of a companies fundamentals and operational strength. Here are some key insights as we drill into the specifics of these quality attributes.
  • BIOL has a Quality Grade of D, ranking ahead of 24.63% of graded US stocks.
  • BIOL's asset turnover comes in at 0.622 -- ranking 66th of 182 Medical Equipment stocks.
  • TCMD, XENT, and KRMD are the stocks whose asset turnover ratios are most correlated with BIOL.

The table below shows BIOL's key quality metrics over time.

Period Asset Turnover Gross Margin ROIC
2021-06-30 0.622 0.330 -0.489
2021-03-31 0.599 0.290 -0.720
2020-12-31 0.673 0.271 -0.847
2020-09-30 0.775 0.368 -0.933
2020-06-30 0.945 0.365 -1.223
2020-03-31 1.103 0.376 -0.989

BIOL Price Target

For more insight on analysts targets of BIOL, see our BIOL price target page. And for a list of of all stocks sorted by upside potential based on analyst target price, see our Top Price Target page.

Average Price Target $2.25 Average Broker Recommendation 1.38 (Strong Buy)

BIOL Stock Price Chart Interactive Chart >

Price chart for BIOL

BIOL Price/Volume Stats

Current price $0.69 52-week high $1.51
Prev. close $0.68 52-week low $0.26
Day low $0.67 Volume 1,648,400
Day high $0.70 Avg. volume 13,482,341
50-day MA $0.65 Dividend yield N/A
200-day MA $0.76 Market Cap 103.60M

Biolase, Inc. (BIOL) Company Bio


BIOLASE, Inc.,a medical device company, develops, manufactures, and markets laser systems in dentistry and medicine in the United States and internationally. It offers Waterlase dental laser systems for cutting soft and hard tissue; and diode laser systems, which are used in soft tissue, pain therapy, and cosmetic procedures, such as teeth whitening. The company was founded in 1984 and is based in Irvine, California.


BIOL Latest News Stream


Event/Time News Detail
Loading, please wait...

BIOL Latest Social Stream


Loading social stream, please wait...

View Full BIOL Social Stream

Latest BIOL News From Around the Web

Below are the latest news stories about Biolase Inc that investors may wish to consider to help them evaluate BIOL as an investment opportunity.

BIOLASE and Healthy Smiles for Kids of Orange County (Healthy Smiles) Invite California Dental Community to Awareness Reception on Sept. 24

BIOLASE, Inc. (NASDAQ: BIOL), the global leader in dental lasers, and Healthy Smiles for Kids of Orange County (Healthy Smiles) are inviting dental professionals in the Orange County area to an awareness reception around the shared mission to improve the oral health of children in the community.

Yahoo | September 14, 2021

7 of the Best Penny Stocks for Any Portfolio

As the global economy recovers in fits and starts, one way to play the long-term expansion in global markets is with solid penny stocks.

Louis Navellier and the InvestorPlace Research Staff on InvestorPlace | September 13, 2021

BIOLASE Schedule Of Investor Conferences For September 2021

BIOLASE, Inc. (NASDAQ: BIOL), the global leader in dental lasers, today announced its schedule of investor conferences for September 2021:

Yahoo | September 8, 2021

BIOLASE Announces Clinical Advisory Partnership with Leading Endodontist Dr. L. Stephen Buchanan

Today BIOLASE, Inc. (NASDAQ: BIOL), the global leader in dental lasers, announced a clinical advisory partnership with Dr. L. Stephen Buchanan that will help expand laser adoption and increase hands-on training programs with one of the global leaders in endodontics.

Yahoo | August 31, 2021

The 6 Best Penny Stocks to Buy for September

Investing in penny stocks can be an intriguing numbers game.

Chris Markoch on InvestorPlace | August 30, 2021

Read More 'BIOL' Stories Here

BIOL Price Returns

1-mo -8.06%
3-mo -6.91%
6-mo -19.66%
1-year 141.60%
3-year -67.91%
5-year -92.85%
YTD 65.59%
2020 -24.61%
2019 -44.17%
2018 -53.95%
2017 -69.29%
2016 66.67%

Continue Researching BIOL

Want to see what other sources are saying about Biolase Inc's financials and stock price? Try the links below:

Biolase Inc (BIOL) Stock Price | Nasdaq
Biolase Inc (BIOL) Stock Quote, History and News - Yahoo Finance
Biolase Inc (BIOL) Stock Price and Basic Information | MarketWatch

Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!


Page generated in 0.7741 seconds.